venBio Select Advisor

Latest statistics and disclosures from Avoro Capital Advisors's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Avoro Capital Advisors

Companies in the Avoro Capital Advisors portfolio as of the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Mirati Therapeutics Common (MRTX) 17.2 $996M +4% 4.5M 219.64
Horizon Therapeutics Common (HZNP) 11.3 $658M +17% 9.0M 73.15
United Therapeutics Corp Common (UTHR) 7.5 $433M NEW 2.9M 151.79
Iovance Biotherapeutics Common (IOVA) 6.0 $348M -21% 7.5M 46.40
Arena Pharmaceuticals Common (ARNA) 5.5 $322M +35% 4.2M 76.83
Ascendis Pharma Sponsored ADR (ASND) 5.2 $300M 1.8M 166.78
Sarepta Therapeutics Common (SRPT) 5.1 $298M +4% 1.8M 170.49
Argenx Se Sponsored ADR (ARGX) 4.6 $265M 903k 294.09
Amicus Therapeutics Common (FOLD) 3.6 $208M -17% 9.0M 23.09
Acceleron Pharma Common (XLRN) 3.4 $198M +14% 1.6M 127.94
Mersana Therapeutics Common (MRSN) 3.1 $181M 6.8M 26.61
Biomarin Pharmaceutical Common (BMRN) 2.5 $145M -5% 1.7M 87.69
Madrigal Pharmaceuticals Common (MDGL) 2.3 $136M +37% 1.2M 111.17
Kura Oncology Common (KURA) 2.2 $131M +64% 4.0M 32.66

Setup an alert

venBio Select Advisor will file the next quarterly 13-HR in about 1 months. Would you like to be notified?

Pmv Pharmaceuticals Common (PMVP) 2.2 $131M +27% 2.4M 55.54
Acadia Pharmaceuticals Common (ACAD) 1.8 $104M NEW 2.0M 53.46
Adverum Biotechnologies Common (ADVM) 1.5 $87M 8.0M 10.84
Trillium Therapeutics Common (TRIL) 1.5 $85M +5% 5.8M 14.71
Constellation Pharmaceuticals Common (CNST) 1.5 $85M -30% 3.0M 28.80
Deciphera Pharmaceuticals Common (DCPH) 1.3 $74M -28% 1.3M 57.07
Praxis Precision Medicines Common (PRAX) 1.2 $69M NEW 1.5M 44.46
Cymabay Therapeutics Common (CBAY) 1.0 $59M 10M 5.74
Iveric Bio Common (ISEE) 0.9 $50M 7.3M 6.91
Travere Therapeutics Common (TVTX) 0.8 $49M NEW 1.8M 27.26
Relmada Therapeutics Common (RLMD) 0.8 $49M 1.5M 32.07
Xenon Pharmaceuticals Common (XENE) 0.7 $43M 2.8M 15.38
Marinus Pharmaceuticals Common (MRNS) 0.7 $39M NEW 3.2M 12.20
Olema Pharmaceuticals Common (OLMA) 0.6 $36M NEW 877k 40.65
Amarin Corp Sponsored ADR (AMRN) 0.5 $29M 6.0M 4.89
Avadel Pharmaceuticals Sponsored ADR (AVDL) 0.5 $29M +3% 4.4M 6.68
Relay Therapeutics Common (RLAY) 0.4 $21M 500k 41.56
Black Diamond Therapeutics Common (BDTX) 0.4 $21M +6% 640k 32.05
Adaptimmune Therapeutics Sponsored ADR (ADAP) 0.3 $19M -67% 3.6M 5.39
Iteos Therapeutics Common (ITOS) 0.3 $16M 460k 33.82
Therapeutics Acquisition Corp Common (RACA) 0.2 $14M 1.0M 13.95
Avidity Biosciences Common (RNA) 0.2 $14M 545k 25.52
Fennec Pharmaceuticals Common (FENC) 0.2 $12M 1.7M 7.45
Genocea Biosciences Common (GNCA) 0.2 $12M 5.1M 2.42
Mannkind Corp Common (MNKD) 0.2 $11M NEW 3.5M 3.13
Syndax Pharmaceuticals Common (SNDX) 0.2 $10M NEW 450k 22.24
Bctg Acquisition Corp Common (BCTG) 0.2 $9.2M 800k 11.44
Cue Biopharma Common (CUE) 0.1 $5.7M -75% 453k 12.51
Athenex Common (ATNX) 0.1 $4.1M -88% 373k 11.06
Nektar Therapeutics Common Call Option (NKTR) 0.0 $26k NEW 100k 0.26

Past Filings by Avoro Capital Advisors

SEC 13F filings are viewable for Avoro Capital Advisors going back to 2014

View all past filings